Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Figure 6 Flap endonuclease-1 modulation regulates the AKT/mTOR signaling pathway in pancreatic cancer.
A: Bubble plot representation of KEGG pathway enrichment analysis for genes differentially co-expressed with flap endonuclease-1 (FEN1) in pancreatic cancer. Bubble size indicates gene count; color intensity represents significance level (-log10 P value); B: GSEA enrichment plot showing correlation between FEN1 co-expressed genes and the mTOR signaling pathway (nominal P value and false discovery rate are indicated); C-F: Western blot analysis of key AKT/mTOR signaling pathway components in PATU8988T and PANC-1 cells following FEN1 knockdown or overexpression. Phosphorylation status and total protein levels were assessed for AKT, mTOR, and downstream effectors. Protein expression was normalized to appropriate loading controls. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Xia Y, Guo N, Zhu CL, Gao JY, Da MX. Flap endonuclease-1 promotes pancreatic cancer progression via AKT/mTOR signaling pathway. World J Gastrointest Oncol 2025; 17(7): 104402
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/104402.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.104402